Pharmacokinetic interactions between Japanese traditional kampo medicine and modern medicine (IV). Effect of Kamisyoyosan and Tokisyakuyakusan on the pharmacokinetics of etizolam in rats

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 2, 2005, Pages 280-284

  Makino, Toshiaki ^a   Inagaki, Takahiro ^a   Komatsu, Ken Ichi ^a   Kano, Yoshihiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Etizolam; Herb drug interaction; Kamisyoyosan; Kampo medicine; Tokisyakuyakusan

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CYTOCHROME P450 3A; ETIZOLAM; HERBACEOUS AGENT; KAMISYOYOSAN; KAMPO; TOKISYAKUYAKUSAN; UNCLASSIFIED DRUG; DIAZEPAM; DRUG DERIVATIVE; KAMISYOYO SAN; TOKI SHAKUYAKU SAN; TOKI-SHAKUYAKU-SAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG COMBINATION; DRUG INFORMATION; DRUG INHIBITION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HERBAL MEDICINE; IN VITRO STUDY; IN VIVO STUDY; LIVER MICROSOME; MAXIMUM ALLOWABLE CONCENTRATION; MENOPAUSAL SYNDROME; NONHUMAN; PHARMACOKINETICS; RAT; STATISTICAL SIGNIFICANCE; TRADITIONAL MEDICINE; ANIMAL; CHINESE MEDICINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG INTERACTION; SPRAGUE DAWLEY RAT;

ANIMALS; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; FEMALE; MEDICINE, KAMPO; RATS; RATS, SPRAGUE-DAWLEY;

EID: 19444365094     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.280     Document Type: Article

References (31)

1. Part III: Makino T., Inagaki T., Komatsu K., Kano Y., Biol. Pharm. Bull., 27, 670-673 (2004).
2. Birge S. J., Clin. Geriatr. Med., 19, 617-627 (2003).
3. Warren M. P., Shortle B., Dominguez J. E., Best Pract. Res. Clin. Obstet. Gynaecol., 16, 411-448 (2002).
4. Chlebowski R. T., Kim J. A., Col N. F., Semin. Oncol., 30, 776-788 (2003).
5. Sun J., J. Altern. Complement. Med., 9, 403-409 (2003).
6. Terasawa K., J. Trad. Med., 20, 1-6 (2003).
7. Shiota Y., Wilson J. G., Matsumoto H., Munemasa M., Okamura M., Hiyama J., Marukawa M., Ono T., Taniyama K., Mashiba H., Intern. Med., 35, 494-496 (1996).
8. Mantani N., Hisanaga A., Kogure T., Kita T., Shimada Y., Terasawa K., Psychiatry Clin. Neurosci., 56, 617-620 (2002).
9. Chen L. C., Tsao Y. T., Yen K. Y., Chen Y. F., Chou M. H., Lin M. F., Maturitas, 44, 55-62 (2003).
10. Ishikawa T., Funahashi T., Kudo J., Psychiatry Clin. Neurosci., 54, 579-582 (2000).
11. Usuki S., Higa T. N., Soreya K., Am. J. Chin. Med., 30, 327-338 (2002).
12. Cupp M. J., Am. Fam. Physician, 59, 1239-1245 (1999).
13. Ishigami M., Kawabata K., Takasaki W., Ikeda T., Komai T., Ito K., Sugiyama Y., Drug Metab. Dispos., 29, 1068-1072 (2001).
14. Mohri K., Uesawa Y., Pharm. Res., 18, 177-182 (2001).
15. Tabata K., Yamaoka K., Kaibara A., Suzuki S., Terakawa M., Hata T., Xenobio. Metab. Dispos., 14, 286-293 (1999).
16. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
17. Araki K., Yasui-Furukori N., Fukasawa T., Aoshima T., Suzuki A., Inoue Y., Tateishi T., Otani K., Eur. J. Clin. Pharmacol., 60, 427-430 (2004).
18. Mohri K., Uesawa Y., Sagawa K., Drug Metab. Dispos., 28, 482-486 (2000).
19. Uno T., Ohkubo T., Sugawara K., Higashiyama A., Motomura S., Ishizaki T., Eur. J. Clin. Pharmacol., 56, 643-649 (2000).
20. Edwards D., Bellevue F. I., Woster P., Drug Metab. Dispos., 24, 1287-1290 (1996).
21. Bailey D., Kreeft J., Munoz C., Freeman D., Bend J., Clin. Pharmacol. Ther., 64, 248-256 (1998).
22. Takahashi K., Uejima E., Morisaki T., Kurokawa K., Azuma J., J. Clin. Pharm. Ther., 28, 319-327 (2003).
23. Iwata H., Tezuka Y., Usia T., Kadota S., Hiratsuka A., Watabe T., J. Trad. Med., 21, 42-50 (2004).
24. Guengerich F. P., Annu. Rev. Pharmacol. Toxicol., 39, 1-17 (1999).
25. Higashikawa F., Murakami T., Kaneda T., Takano M., J. Pharm. Pharmacol., 51, 405-410 (1999).
26. Noguchi M., Kubo M., Hayashi T., Ono M., Chem. Pharm. Bull., 26, 3652-3657 (1978).
27. Tanaka T., Fukumori M., Ochi T., Kouno I., J. Nat. Prod., 66, 759-763 (2003).
28. Geisser P., Arzneimittelforschung, 40, 754-760 (1990).
29. Ernst E., Eur. J. Clin. Pharmacol., 56, 523-524 (2000).
30. Ioannides C., Xenobiotica, 32, 451-478 (2002).
31. Akao T., Kida H., Kanaoka M., Hattori M., Kobashi K., J. Pharm. Pharmacol., 50, 1155-1160 (1998).